Beyond the prescription: how movement anchors GLP-1 success and saves employers millions

GLP-1 medications are transforming obesity care. Without addressing inactivity and muscle loss, employers risk a new wave of MSK claims. Up to 70% of GLP-1 users discontinue use within a year¹, and many regain weight after treatment ends. Movement is the missing link to lasting results, improved quality of life, and sustainable cost control.

GLP-1s can cost employers up to $10,000 per member annually², yet many of these dollars are going to members without long-term habit change.

Leading employers are solving for this risk by adding structured movement plans to support GLP-1 use and protect lean muscle mass.

In this exclusive white paper, Sword Health explores how Sword Move complements GLP-1 strategies by reinforcing sustainable physical activity. If your organization is investing in GLP-1s, this is essential reading.

Muscle retention is an ROI-protector for GLP-1 care plans

• Up to 39% of lean body mass is lost during GLP-1 use⁵
• 1 in 4 Americans engage in regular physical activity⁶
• Inactivity contributes to 27% of total employee medical spend⁷
• Sarcopenia contributes nearly $900 in excess healthcare costs per employee each year⁸
• 78% of Move users report feeling moderately better or much better⁹
• 69% of active and insufficiently active members members reach active or healthy active status within 10 weeks¹⁰